ROSS\JOHNSON & Associates »

Alnylam Pharmaceuticals shares owned by ROSS\JOHNSON & Associates

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by ROSS\JOHNSON & Associates from 13F filings

Historical chart of ROSS\JOHNSON & Associates investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by ROSS\JOHNSON & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by ROSS\JOHNSON & Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $456 1 456.00
2025-06-30 $326 1 326.00
2025-03-31 $270 1 270.00

More positions owned by ROSS\JOHNSON & Associates

Graco Common / Ordinary Stock (GGG)
Spdr S&p 500 Etf Tr Exchange Traded Fund (SPY)
Tesla Common / Ordinary Stock (TSLA)
Ishares Tr Exchange Traded Fund (MUB)
Ishares Tr Exchange Traded Fund (IVV)
Sei Exchange Traded Funds Exchange Traded Fund (SEEM)
Ark 21shares Bitcoin Etf Exchange Traded Fund (ARKB)
Bitwise Bitcoin Etf Tr Exchange Traded Fund (BITB)
Sei Exchange Traded Funds Exchange Traded Fund (SEIS)
Benchmark Electrs Common / Ordinary Stock (BHE)
Wells Fargo Common / Ordinary Stock (WFC)
Amgen Common / Ordinary Stock (AMGN)
Unitedhealth Group Common / Ordinary Stock (UNH)
Cisco Sys Common / Ordinary Stock (CSCO)
Invesco Exch Traded Fd Tr Ii Exchange Traded Fund (QQQM)

View all positions for ROSS\JOHNSON & Associates

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals